535 related articles for article (PubMed ID: 8113680)
1. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo.
Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H
J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680
[TBL] [Abstract][Full Text] [Related]
2. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
3. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083
[TBL] [Abstract][Full Text] [Related]
4. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.
Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H
Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474
[TBL] [Abstract][Full Text] [Related]
5. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
6. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
[TBL] [Abstract][Full Text] [Related]
7. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens.
Wettstein PJ; Korngold R
Transplantation; 1992 Aug; 54(2):296-307. PubMed ID: 1353915
[TBL] [Abstract][Full Text] [Related]
8. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
9. Two levels of help for B cell alloantibody production.
Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H
J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185
[TBL] [Abstract][Full Text] [Related]
10. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
11. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
13. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
Martin PJ
Blood; 1996 Aug; 88(3):962-9. PubMed ID: 8704255
[TBL] [Abstract][Full Text] [Related]
14. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
15. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
16. Xenogeneic iso-skin graft and mixed lymphocyte reaction studies using HLA-DP transgenic mice.
Hagihara M; Shimura T; Takebe K; Munkhbat B; Sato T; Tsuchida F; Sato K; Tsuji K
Transpl Immunol; 1996 Sep; 4(3):220-6. PubMed ID: 8893453
[TBL] [Abstract][Full Text] [Related]
17. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
Riddle DS; Miller PJ; Vincent BG; Kepler TB; Maile R; Frelinger JA; Collins EJ
Eur J Immunol; 2008 Jun; 38(6):1511-21. PubMed ID: 18465769
[TBL] [Abstract][Full Text] [Related]
18. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
19. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
Nevala WK; Paul C; Wettstein PJ
Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
[TBL] [Abstract][Full Text] [Related]
20. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]